What I learned was that the puppies were characters in a TV show called Paw Patrol, which is about the adventures of a ...

The Panini Fan Experience opens Wednesday, Feb. 5 at 3 p.m. It’s at the Ernest N. Memorial Convention Center and features ...

“I want my kids to be goal setters.” Barkley shares Jada and Saquon Jr. with his college sweetheart, Anna Congdon. Read on to learn more about the family who will cheering on Barkley at Super ...

House Minority Leader Hakeem Jeffries (D-N.Y.) made a last-minute endorsement in the race for Democratic National Committee (DNC) chair on Friday, backing Wisconsin state party chair Ben Wikler.

After fans spent time on the field enjoying the food trucks and live music, it was time for the big announcement. New Hooks ...

The White House on Friday called for House Minority Leader Hakeem Jeffries (D-N.Y.) to apologize for remarks pledging to push back against the Trump administration’s agenda. Jeffries at a press ...

(Bloomberg) -- Jefferies Financial Group Inc. hired Tim Kerry from Barclays Plc as the bank builds up its ranks to prepare for a wave of M&A-related financings. Kerry will join Jefferies as co ...

House Minority Leader Rep. Hakeem Jeffries, D-NY, joins Morning Joe to discuss the midair crash near Reagan airport between an Army helicopter and passenger plane. Leader Jeffries also discusses ...

In the largely Latino Hermosa neighborhood on the city’s northwest side, a frightened young woman who only gave her name as Melissa told a Chicago Tribune reporter that her parents ran and hid in ...

In a report released yesterday, Charles Bentley, CFA from Jefferies maintained a Sell rating on Givaudan SA (GIVN – Research Report), with a price target of CHF3,400.00. In addition to Jefferies ...

House Minority Leader Hakeem Jeffries put GOP leaders on notice Thursday that they can’t take Democratic votes for granted when it comes to lifting the statutory debt ceiling by this summer’s ...

Jefferies has upgraded Crinetics Pharmaceuticals (NASDAQ:CRNX) to buy, citing a recent pullback in the stock on investor concerns about Phase 2 data for the company's drug atumelnant in the ...